Search results

In a new-look venture climate, stock options and other types of company equity might be losing some of their luster in the eyes of employees.

Fundraising for pre-seed companies stayed robust in Q1 2024, dominated by SAFEs and convertible notes; valuation caps remained flat.

The median venture round size increased at every stage from seed to Series C during Q1 2024, a welcome development for cash-hungry startups.

An increasing number of seed-stage rounds are extension financings, or bridge rounds.

Valuations and round sizes rose at most stages in Q1 2024.

Headcount contracted across the startup ecosystem as companies continue to adjust compensation strategies in response to economic headwinds.

Median seed valuations trended up in Q4 in the healthtech, consumer, and fintech sectors. In other key metrics, the numbers weren’t so rosy.

Between Q1 2021 and Q1 2022, the number of M&A deals targeting startups on Carta increased by 79%.

As the count of new seed deals steadily shrinks, some founders are finding new funding paths.

Valuation step-up multiples trended up last year at Series A and Series B. Series C was a different story.

Last year’s figures in late-stage dealmaking were far off the late-stage market’s peak in 2021. They’re also still lagging behind the pre-pandemic funding market of 2019.